|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,617.80 INR | +4.90% |
|
-3.04% | -10.99% |
| 30/01 | Ajanta Pharma Limited, Q3 2025 Earnings Call, Jan 30, 2025 | |
| 30/01 | Ajanta Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 | CI |
| Capitalization | 31TCr 359.43Cr 344.16Cr 325.1Cr 286.67Cr 510.95Cr 570.46Cr 3.87TCr 1.44TCr 13TCr 1.35TCr 1.32TCr 55TCr | P/E ratio 2025 * |
33.8x | P/E ratio 2026 * | 28.9x |
|---|---|---|---|---|---|
| Enterprise value | 31TCr 359.43Cr 344.16Cr 325.1Cr 286.67Cr 510.95Cr 570.46Cr 3.87TCr 1.44TCr 13TCr 1.35TCr 1.32TCr 55TCr | EV / Sales 2025 * |
6.76x | EV / Sales 2026 * | 5.97x |
| Free-Float |
33.52% | Yield 2025 * |
0.76% | Yield 2026 * | 0.77% |
More valuation ratios
* Estimated data
More news
Last Transcript: Ajanta Pharma Limited
More press releases
| 1 day | +2.28% | ||
| 1 week | -5.17% | ||
| Current month | -5.27% | ||
| 1 month | -9.35% | ||
| 3 months | -10.75% | ||
| 6 months | -16.20% | ||
| Current year | -12.95% |
1 week
2 450.90
2 683.60
1 month
2 450.903 079.90
Current year
2 450.903 094.25
1 year
1 998.353 485.00
3 years
1 061.773 485.00
5 years
640.673 485.00
10 years
550.003 485.00
| Director | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 48 | - | |
| Chief Executive Officer | 53 | 21/12/2009 | |
| Director of Finance/CFO | 60 | 23/04/1998 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | 01/01/1996 | |
| Chairman | 77 | 31/12/1979 | |
| Director/Board Member | 69 | 21/12/2009 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 0 M€ | -4.41% | - | |
| 0% | 89 M€ | +2.69% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.51% | -5.17% | +20.69% | +88.48% | 359.43Cr | ||
| -3.15% | -3.41% | +11.17% | +95.43% | 4.83TCr | ||
| -9.80% | -7.58% | +34.80% | +84.79% | 2.85TCr | ||
| -0.41% | +1.97% | +57.96% | - | 2.18TCr | ||
| -0.82% | -0.82% | +2.45% | +52.92% | 1.37TCr | ||
| -4.07% | -8.97% | +4.29% | +136.51% | 1.09TCr | ||
| -.--% | +0.14% | - | - | 678.76Cr | ||
| -.--% | -1.95% | - | - | 572.55Cr | ||
| -0.30% | -0.91% | +38.56% | +44.05% | 525.05Cr | ||
| +1.40% | +3.92% | +13.01% | +37.56% | 505.87Cr | ||
| Average | -1.48% | -0.90% | +22.87% | +77.11% | 1.5TCr | |
| Weighted average by Cap. | -3.24% | +0.01% | +23.46% | +86.55% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 4.61TCr 53Cr 51Cr 48Cr 42Cr 76Cr 84Cr 572.64Cr 212.45Cr 1.92TCr 199.27Cr 195.31Cr 8.13TCr | 5.22TCr 60Cr 58Cr 54Cr 48Cr 86Cr 96Cr 648.09Cr 240.44Cr 2.17TCr 225.52Cr 221.04Cr 9.2TCr |
| Net income | 925.47Cr 11Cr 10Cr 9.65Cr 8.51Cr 15Cr 17Cr 114.95Cr 43Cr 385.31Cr 40Cr 39Cr 1.63TCr | 1.09TCr 13Cr 12Cr 11Cr 10Cr 18Cr 20Cr 135Cr 50Cr 452.52Cr 47Cr 46Cr 1.92TCr |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
8,073
Sector
Pharmaceuticals
Calendar
01/05/2025
- Q4 2025 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/25/14 | 2,617.80 ₹ | +4.90% | 289,075 |
| 13/25/13 | 2,495.60 ₹ | -0.77% | 102,407 |
| 12/25/12 | 2,515.05 ₹ | -0.21% | 123,090 |
| 11/25/11 | 2,520.30 ₹ | -3.04% | 61,403 |
| 10/25/10 | 2,599.20 ₹ | -3.44% | 71,591 |
Delayed Quote NSE India S.E., February 14, 2025 at 01:40 pm IST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
2,495.60INR
Average target price
3,029.90INR
Spread / Average Target
+21.41%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AJANTPHARM Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition